Australia - English - Department of Health (Therapeutic Goods Administration)

maxx pharma pty ltd - eslicarbazepine acetate, quantity: 800 mg - tablet, uncoated - excipient ingredients: magnesium stearate; croscarmellose sodium; povidone - zebinix is indicated as:,? monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;,? adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

maxx pharma pty ltd - eslicarbazepine acetate, quantity: 200 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; croscarmellose sodium - zebinix is indicated as:,? monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;,? adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Israel - English - Ministry of Health

truemed ltd, israel - eslicarbazepine acetate - tablets - eslicarbazepine acetate 200 mg - eslicarbazepine - zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Israel - English - Ministry of Health

truemed ltd, israel - eslicarbazepine acetate - tablets - eslicarbazepine acetate 800 mg - eslicarbazepine - zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eslicarbazepine acetate - tablet - 800mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eslicarbazepine acetate - tablet - 200mg

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - eslicarbazepine acetate - tablet - eslicarbazepine acetate 800 mg - antiepileptics

United Kingdom - English - myHealthbox

bayer ag -

United Kingdom - English - myHealthbox

bayer ag -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - metalaxyl-m; sedaxane; difenoconazole - suspension concentrates for seed treatment (fs) - metalaxyl-m phenylamide active 16.5 g/l; sedaxane pyrazole active 13.8 g/l; difenoconazole triazole active 66.2 g/l - fungicide - barley | oats | triticale | wheat - covered smut - u. segetum var. segetum | covered smut (bunt) - tilletia spp. | flag smut on cereal | loose smut - ustilago avenae | loose smut - ustilago tritici | loose smut (ustilago spp.) - suppression | rhizoctonia brown patch | root rot - phytophthora spp. | spot form net blotch - pyrenophora teres | bare patch | bunt | common bunt | rhizoctonia solani | seedborne flag smut | soilborne flag smut | suppression | ustilago nuda (tritici)